B-Cell Non-Hodgkin Lymphoma

Showing NaN - NaN of 1

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

B-cell Non-Hodgkin Lymphoma Trial in Worldwide (Mosunetuzumab (IV), Mosunetuzumab (SC), Polatuzumab vedotin)

Recruiting
  • B-cell Non-Hodgkin Lymphoma
  • Mosunetuzumab (IV)
  • +4 more
  • Birmingham, Alabama
  • +28 more
Jan 6, 2023